Showing results (181-190 of 204) with videos related to
Sort By:
Pageof 21
Scientific Reports|October 29, 2024
A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasisHuiwei Wang, Jialiang Shi, Suchun Hou, et al.American Journal of Respiratory and Critical Care Medicine|March 4, 2006
A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysemaIrina Petrache, Iwona Fijalkowska, Lijie Zhen, et al.Diabetes|July 25, 2009
Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic miceMatthew J Parker, Song Xue, John J Alexander, et al.Journal of Medical Microbiology|March 23, 2017
Origin and distribution of Sporothrix globosa causing sapronoses in AsiaTarek A A Moussa, Naif M S Kadasa, Hassan S Al Zahrani, et al.Clinical Microbiology Reviews|November 19, 2016
ChromoblastomycosisFlavio Queiroz-Telles, Sybren de Hoog, Daniel Wagner C L Santos, et al.Allergy|October 25, 2024
Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trialYan Zhao, Litao Zhang, Liming Wu, et al.Chinese Medical Journal|July 23, 2023
Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trialYan Zhao, Jianzhong Zhang, Bin Yang, et al.Dermatitis : Contact, Atopic, Occupational, Drug|March 28, 2025
Long-Term Stapokibart Treatment Induces Sustained Clinical Improvements in Patients With Moderate-to-Severe Atopic DermatitisYan Zhao, Litao Zhang, Liming Wu, et al.International Journal of Dermatology|November 22, 2025
Efficacy and Safety of Anti-IL-4Rα Stapokibart in Elderly Patients With Moderate-To-Severe Atopic DermatitisYan Zhao, Litao Zhang, Liming Wu, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 15, 2023
Nail psoriasis in China: A prospective multicentre studyShiqi Wang, Jianjian Zhu, Ping Wang, et al.Pageof 21